1. Home
  2. LPCN vs FENG Comparison

LPCN vs FENG Comparison

Compare LPCN & FENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lipocine Inc.

LPCN

Lipocine Inc.

HOLD

Current Price

$2.50

Market Cap

19.1M

Sector

Health Care

ML Signal

HOLD

Logo Phoenix New Media Limited

FENG

Phoenix New Media Limited

N/A

Current Price

$1.56

Market Cap

20.2M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
LPCN
FENG
Founded
1997
1998
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
19.1M
20.2M
IPO Year
2011
2011

Fundamental Metrics

Financial Performance
Metric
LPCN
FENG
Price
$2.50
$1.56
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
115.1K
8.3K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
46.18
N/A
EPS
N/A
N/A
Revenue
$1,976,677.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$92.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.81
$1.52
52 Week High
$12.37
$3.65

Technical Indicators

Market Signals
Indicator
LPCN
FENG
Relative Strength Index (RSI) 54.43 38.99
Support Level $2.16 N/A
Resistance Level $2.46 $1.82
Average True Range (ATR) 0.18 0.06
MACD 0.07 -0.01
Stochastic Oscillator 69.97 12.00

Price Performance

Historical Comparison
LPCN
FENG

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

About FENG Phoenix New Media Limited

Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives all of its revenue from PRC.

Share on Social Networks: